NCT02890589View on ClinicalTrials.gov

Strut Coverage With SYNERGY Stents and Bioresorbable Vascular Scaffold in Acute Myocardial Infarction

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Acute Coronary Syndrome
Interventions
DEVICE

SYNERGY stent

"Coronary angiography will assess the presence of at least one eligible coronary lesion requiring stent implantation before revascularization by angioplasty.~Stent will be implanted according to manufacturer's and competent authority recommendations."

DEVICE

ABSORB (Everolimus-eluting Bioresorbable Vascular Scaffold)

"Coronary angiography will assess the presence of at least one eligible coronary lesion requiring stent implantation before revascularization by angioplasty.~Stent will be implanted according to manufacturer's and competent authority recommendations."

Trial Locations (1)

31500

Didier CARRIE, Toulouse

Sponsors
All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

lead

University Hospital, Toulouse

OTHER